One thing to keep in mind: Some meals are relatively high in fat, including saturated fat, which may aggravate gastrointestinal side effects in some GLP-1 users
Given the results from recent studies, the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) recommend that patients with T2D and clinical cardiovascular disease (CVD) with inadequate glucose control despite treatment with metformin should receive an SGLT2 inhibitor or GLP-1 receptor agonist
The 3-Month Starter Plan: Building Your Foundation Your first three months focus on establishing consistency and allowing your body to adapt
Here, well delve into the intricacies of maintaining GLP-1 medications, set expectations on how long patients should stay on GLP-1 medications, and offer insights into the best practices for patients looking to stop their GLP-1 journey
Patients typically begin therapy within days rather than waiting weeks for insurance authorization
We recommend, as always, that you talk to your family's healthcare providers about any options you are interested in pursuing